Perfil
Pawel Krysiak is currently the President & Chief Executive Officer at M6P Therapeutics.
Cargos activos de Pawel Krysiak
| Empresas | Cargo | Inicio |
|---|---|---|
M6P Therapeutics
 M6P Therapeutics BiotechnologyHealth Technology M6P Therapeutics is a biotechnology company that develops targeted recombinant enzyme and gene therapies for lysosomal storage disorders. M6P Therapeutics is based in St. Louis, MO and their mission is to translate advanced science into therapies that address unmet needs within the LSD community. The private company's proprietary bicistronic-s1s3 platform enhances phosphorylation of lysosomal enzymes for both recombinant enzyme and gene therapies, leading to improved biodistribution and cellular uptake of recombinant proteins and efficient cross-correction of gene therapy product. The company was founded in 2017 by Cuong Viet Do, Stuart Kornfeld, Lin Liu, and the CEO is Pawel Krysiak. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
M6P Therapeutics
M6P Therapeutics BiotechnologyHealth Technology M6P Therapeutics is a biotechnology company that develops targeted recombinant enzyme and gene therapies for lysosomal storage disorders. M6P Therapeutics is based in St. Louis, MO and their mission is to translate advanced science into therapies that address unmet needs within the LSD community. The private company's proprietary bicistronic-s1s3 platform enhances phosphorylation of lysosomal enzymes for both recombinant enzyme and gene therapies, leading to improved biodistribution and cellular uptake of recombinant proteins and efficient cross-correction of gene therapy product. The company was founded in 2017 by Cuong Viet Do, Stuart Kornfeld, Lin Liu, and the CEO is Pawel Krysiak. | Health Technology |
- Bolsa de valores
- Insiders
- Pawel Krysiak
